Displaying 1–25 of 40 results for Paul Thomas, Contributing Editor

Sort By Relevance Sort By Date
1 2

Tracing NIR's Trajectory for Bioprocess Monitoring

(Article)

By better combining and interpreting readily available data, biomanufacturing experts are improving control of fermentation and other processes, says Sartorius’ Roland Bienert.

Tracing NIR’s Trajectory for Bioprocess Monitoring

(Article)

By better combining and interpreting readily available data, biomanufacturing experts are gaining better control of fermentation and other processes, says Sartorius’ Roland Bienert

Tracing NIR’s Trajectory for Bioprocess Monitoring

(Article)

By better combining and interpreting readily available data, biomanufacturing experts are gaining better control of fermentation and other processes, says Sartorius’ Roland Bienert.

PharmaView: Single-Use Standards: What’s the Rush?

(Article)

Can standardization and innovation coexist?

Are Single-Use Standards Stuck? And Is That a Bad Thing?

(Article)

Efforts to enact meaningful standards for single-use bioprocessing technologies move at a snail's pace, with no clear path forward, experts say.

Town Hall: FDA Braces for PDUFA V, Possible Loss of Biosimilars Authority

(Article)

Janet Woodcock looks forward to having more cash and resources with new user fee legislation. Meanwhile, she raises concerns about the Agency’s authority over biosimilars should the Supreme Court strike down the Affordable Care Act.

Bayer: Keeping Data Cold and Green

(Article)

An interview with Thomas Schilling on the company’s Green IT initiative.

Pharma Sustainability Is on a Roll

(Article)

Drug industry environmental stewardship projects are becoming more sophisticated and challenging. Here are examples from AstraZeneca, Bayer, DSM, Pfizer, and EMD Millipore

EMD Millipore: Giving and Receiving Single-Use Systems

(Article)

A talk with sustainability manager Johanna Jobin about the company's new product recycling initiative.

Striving for a Better Prefilled Syringe

(Article)

West and Vetter look to meet the needs of parenteral manufacturers demanding new, safer syringe options.

Shoring Up Pharma’s Middle Management

(Article)

Organizations with built-in risk management frameworks allow middle managers to thrive, says Scott Chizzo, Maxiom Group’s president and chief consultant, in this exclusive interview.

Temporary Workers: Pharma's Contingency Planning

(Article)

Consultant Steve Sawin answers our questions about managing contingent labor.

PharmaView: Our Employability Challenge

(Article)

It may be hard to find good help, but it’s also hard to find good work.

PharmaView: Where Everybody Knows Your Name

(Article)

If Ashton Kutcher were in pharma, he’d be on LinkedIn.

Drugs in Wastewater: A Call for More Research, More Responsibility

(Article)

Manufacturers must practice a heightened sense of "Pharmecovigilance" regarding drug compounds leaving their facilities as waste, says a leading expert.

Contract Manufacturing: Orchestrating the Dance

(Article)

Lean Six Sigma, expertise in microbiology, and shop-floor experience all contribute to running a flexible, efficient contract facility, says DPT’s new director of sterile ops.

The “Intended” Consequences of Software Validation

(Article)

Compliance specialist Michael Gregor puts the spotlight on software validation, and tells us why FDA is doing the same.

Flexible Pharma: Puzzling Out the Plant of the Future

(Article)

The need to improve agility and reduce financial risk is driving new approaches to plant design and operation, and the use of new technologies. Industry experts look at the future pharmaceutical plant from all angles.

Pharma’s Green Evolution

(Article)

Big Pharma has gone green, but smaller manufacturers have yet to flip the switch, say industry experts and our own survey.

PDA Puts Its Weight Behind Paradigm Change

(Article)

This is no me-too effort, PDA’s Levy says.

Pfizer's Gabapentin Goes Green

(Article)

Pfizer Singapore site leader Stella Eccles talks about making gabapentin (Neurontin) green, and keeping its production viable.

IFPAC’s Cruel and Unusual Program

(Article)

For a “specialized” show, IFPAC 2009 is a lot to take in.

50 Years, and Counting, for Gas-Phase Chromatography

(Article)

Dr. Harold McNair was there when gas chromatography began, but considers his greatest achievements to have come as a teacher and mentor.

When Less is Much, Much More

(Article)

Microreactors are challenging the concept of "economies of scale."

Sort By Relevance Sort By Date
1 2